1. 30PP21 has the potential to become the monitoring marker for the CDK4/6 inhibitors resistance in breast cancer. (23rd October 2018) Authors: Iida, M; Nakamura, M; Tokuda, E; Niwa, T; Ishida, T; Hayashi, S-I Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗